Cathepsin L pseudogene 3 (CTSLP3)

Cathepsin L pseudogene 3 (CTSLP3) is one of several cathepsin L-related pseudogenes within the human genome. Unlike active cathepsin L enzymes, which are lysosomal cysteine proteases with roles in antigen processing, protein degradation, and cell regulation, CTSLP3 lacks evidence of producing a functional protein and has not been detected at the expression or protein level[2][6]. Pseudogenes such as CTSLP3 generally do not participate in canonical biological pathways or serve as therapeutic targets. There is currently no evidence that CTSLP3 is involved in disease, biomarker studies, or drug interaction networks. Key points: - CTSLP3 is not considered a therapeutic target, as it is a pseudogene, not a functional enzyme, receptor, nor involved in any known signaling pathway[6][2]. - There is no evidence of protein expression or biological activity for this gene product in humans[2][6]. - The presence of 'pseudogene' in its name signals its non-functional status, and annotations indicate it does not encode a protein relevant to human biology or disease diagnostics. If you are seeking information about active cathepsin L enzymes, these are functional and have established biological roles and disease associations, and are considered drug targets in some contexts[1][4][5]. However, Cathepsin L pseudogene 3 is not one of them.

Other names

CTSL1P3CTSLL3cathepsin L-like 3cathepsin L1 pseudogene 3

None